Purifying method of pomalidomide
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHANGHAI INST OF PHARMA IND CO LTD
- Publication Date
- 2017-09-22
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2
Abstract
Description
[0001] This application is a divisional application of the following application: filing date: October 29, 2013; application number: 201310520848.2; invention title: "a purification method for polilidomide". technical field
[0002] The invention relates to a method for purifying polilidomide. Background technique
[0003] Pomalidomide, the English name is Pomalidomide, the chemical name is 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione, and its chemical structure is as follows:
[0004]
[0005] Polidomide is a new type of immunomodulator originally developed by Celgene. Polidomide is a derivative of thalidomide, which can regulate T cells and inhibit their proliferation, and play an immunoregulatory role; by activating natural killer ( natural killer) cells, promote the apoptosis of tumor cells, and are mainly used clinically for the treatment of multiple myeloma.
[0006] CN101253163 provides a kind of preparation method of high-purity polilidomide, the mixt...